Optimization of the Antibacterial Spectrum and the Developability Profile of the Novel-Class Natural Product Corramycin-Reference-Cited by-同舟云学术

Optimization of the Antibacterial Spectrum and the Developability Profile of the Novel-Class Natural Product Corramycin

Published:2023-12-13 Issue:24 Volume:66 Page:16869-16887
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Renard Stephane¹,Versluys Stéphanie²,Taillier Thomas³,Dubarry Nelly¹,Leroi-Geissler Corinne¹,Rey Astrid³,Cornaire Emilie³,Sordello Sylvie²,Carry Jean-Christophe B.⁴^ORCID,Angouillant-Boniface Odile⁴,Gouyon Thierry⁴,Thompson Fabienne⁴,Lebourg Gilles⁴,Certal Victor⁴,Balazs Laszlo⁴,Arranz Esther⁴,Doerflinger Gilles⁴,Bretin Francois⁴,Gervat Vincent⁴,Brohan Eric⁴,Kraft Volker⁵,Boulenc Xavier¹,Ducelier Cécile⁶,Bacqué Eric³,Couturier Cédric³^ORCID

Affiliation:

1. Evotec, 40 Avenue Tony Garnier, Lyon 69007, France

2. Evotec, 195, Route d’Espagne, Toulouse 31100, France

3. Evotec, 1541, Avenue Marcel Mérieux, Marcy L’Etoile 69280, France

4. Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France

5. Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt am Main 65926, Germany

6. Sanofi, 1 Avenue Pierre Brossolette, Chilly-Mazarin 91385, France

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link